Evicenter
Rexulti (brexpiprazole) in Major depressive disorder
Manufacturer
Otsuka America Pharmaceutical, Inc.; Lundbeck
Prescribing information
Rexulti (opens in a new tab)
Questions
35
Last updated

All questions

Safety: Rexulti (brexpiprazole) in major depressive disorder

9 questions · 3 sources

Warnings

Rexulti and suicidal thoughts: what are the risks and monitoring steps?

“In pooled analyses of placebo-controlled trials of antidepressant drugs (SSRIs and other antidepressant classes) that included approximately 77,000 adult patients and over 4,400 pediatric patients, the incidence of suicidal thoughts and behaviors in patients 24 years of age and younger was greater in antidepressant-treated patients than in placebo-treated patients. The drug-placebo differences in the number of cases of suicidal thoughts and behaviors per 1,000 patients treated are provided in Table 2. No suicides occurred in any of the pediatric studies. There were suicides in the adult studies, but the number was not sufficient to reach any conclusion about antidepressant drug effect on suicide. Table 2 Risk Differences of the Number of Patients with Suicidal Thoughts or Behaviors in the Pooled Placebo-Controlled Trials of Antidepressants in Pediatric* and Adult Patients Age Range (years) Drug-Placebo Difference in Number of Patients with Suicidal Thoughts or Behaviors per 1,000 Patients Treated Increases Compared to Placebo <18 14 additional patients 18 to 24 5 additional patients Decreases Compared to Placebo 25 to 64 1 fewer patient ≥65 6 fewer patients *REXULTI is not approved in pediatric patients with MDD. It is unknown whether the risk of suicidal thoughts and behaviors in children, adolescents, and young adults extends to longer-term use, i.e., beyond four months. However, there is substantial evidence from placebo- controlled maintenance studies in adults with MDD that antidepressants delay the recurrence of depression. Monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors, especially during the initial few months of drug therapy and at times of dosage changes. Counsel family members or caregivers of patients to monitor for changes in behavior and to alert the healthcare provider. Consider changing the therapeutic regimen, including possibly discontinuing REXULTI, in patients whose depression is persistently worse or who are experiencing emergent suicidal thoughts or behaviors.” (opens the source at this quote in a new tab)

Can Rexulti cause dizziness or low blood pressure when standing?

Can Rexulti cause drowsiness or affect driving?

Side effects

What are the most common side effects of Rexulti for depression?

Note: Table 8 columns are placebo, REXULTI 1 mg/day, 2 mg/day, 3 mg/day, and all REXULTI, in that order (% of patients); the table continues on the next page with restlessness.

How many patients stopped Rexulti for side effects in depression trials?

Note: Figures are from the two 6-week placebo-controlled adjunctive MDD studies (Studies 1 and 2).

Does Rexulti cause akathisia or restlessness in depression trials?

Note: The last passage is from the MDD leave-behind that the resources page of the Rexulti HCP site links; it cites a 2015 conference poster analyzing Studies 1 and 2 (Weiss et al., ASCP 2015).

How much weight gain does Rexulti cause in depression trials?

Note: Table 6 columns are placebo, REXULTI 1 mg/day, 2 mg/day, and 3 mg/day, in that order; the table begins on one page and continues on the next.

What are the long-term side effects of Rexulti (52-week depression studies)?

Note: The open-label depression studies had no placebo control.

Does Rexulti cause sexual side effects such as decreased libido?

Note: Rates are from the two 6-week placebo-controlled adjunctive MDD studies, as reported on the safety page of the Rexulti HCP site, which cites data on file.